Skip to content
10-Q

Quarterly Report

American Oncology Network, Inc.

0001628280-24-037242

← back to feed
Filed
Aug 14, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2024 · Jun 30, 2024 37.09M sh
Shares Diluted Q2 2024 · Jun 30, 2024 36.43M sh
Shares Diluted Q2 2024 · Jun 30, 2023 0 sh
Shares Diluted Q2 2024 · Jun 30, 2023 0 sh
Stock Repurchased Q2 2024 · Jun 30, 2024 $368K
Stock Repurchased restated Q2 2024 · Jun 30, 2023 $0
Capex Q2 2024 · Jun 30, 2024 $8.18M
Capex Q2 2024 · Jun 30, 2023 $6.9M
Operating Cash Flow Q2 2024 · Jun 30, 2024 $11.21M
Operating Cash Flow restated Q2 2024 · Jun 30, 2023 −$2.27M
Long Term Debt Q2 2024 · Jun 30, 2024 $88.24M
Long Term Debt Q2 2024 · Dec 31, 2023 $80.64M
Short Term Debt Q2 2024 · Jun 30, 2024 $3.81M
Short Term Debt Q2 2024 · Dec 31, 2023 $0
Cash And Equivalents Q2 2024 · Jun 30, 2024 $33.82M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $28.54M
Stockholders Equity Q2 2024 · Jun 30, 2024 −$39.98M
Stockholders Equity Q2 2024 · Dec 31, 2023 −$161.73M
Current Liabilities Q2 2024 · Jun 30, 2024 $231.56M
Current Liabilities Q2 2024 · Dec 31, 2023 $169.05M
Total Liabilities Q2 2024 · Jun 30, 2024 $376.91M
Total Liabilities Q2 2024 · Dec 31, 2023 $303.74M
Current Assets Q2 2024 · Jun 30, 2024 $306.26M
Current Assets Q2 2024 · Dec 31, 2023 $277.8M
Total Assets Q2 2024 · Jun 30, 2024 $430.76M
Total Assets Q2 2024 · Dec 31, 2023 $374.45M
Eps Diluted Q2 2024 · Jun 30, 2024 −$110.00
Eps Diluted Q2 2024 · Jun 30, 2024 −$840.00
Eps Diluted Q2 2024 · Jun 30, 2023 $0.00
Eps Diluted Q2 2024 · Jun 30, 2023 $0.00
Eps Basic Q2 2024 · Jun 30, 2024 $120.00
Eps Basic Q2 2024 · Jun 30, 2024 −$740.00
Eps Basic Q2 2024 · Jun 30, 2023 $0.00
Eps Basic Q2 2024 · Jun 30, 2023 $0.00
Sga Expense Q2 2024 · Jun 30, 2024 $36.74M
Sga Expense Q2 2024 · Jun 30, 2024 $65.02M
Sga Expense Q2 2024 · Jun 30, 2023 $23.92M
Sga Expense Q2 2024 · Jun 30, 2023 $47.63M
Net Income Q2 2024 · Jun 30, 2024 $3.29M
Net Income Q2 2024 · Jun 30, 2024 −$4.51M
Operating Income Q2 2024 · Jun 30, 2024 −$8.01M
Operating Income Q2 2024 · Jun 30, 2024 −$27.25M
Operating Income restated Q2 2024 · Jun 30, 2023 −$3.66M
Operating Income restated Q2 2024 · Jun 30, 2023 −$4.15M
Cost Of Revenue Q2 2024 · Jun 30, 2024 $404.59M
Cost Of Revenue Q2 2024 · Jun 30, 2024 $759.54M
Cost Of Revenue Q2 2024 · Jun 30, 2023 $291.4M
Cost Of Revenue Q2 2024 · Jun 30, 2023 $569.93M
Revenue Q2 2024 · Jun 30, 2024 $433.98M
Revenue Q2 2024 · Jun 30, 2024 $798.32M
Revenue Q2 2024 · Jun 30, 2023 $314.97M
Revenue Q2 2024 · Jun 30, 2023 $618.7M